title: Recent advances toward the clinical application of bone morphogenetic proteins in bone and cartilage repair.
abstract: Inefficient healing of bony and cartilaginous defects is a common situation encountered by orthopedic surgeons. Enhancing the regenerative potential of bone and articular cartilage has the potential for profound applications in treatment of nonunions, large segmental bone and cartilage defects, and arthritis. The bone morphogenetic proteins (BMPs) encode a highly conserved class of signaling factors that possess the ability to induce ectopic cartilage and bone formation in vivo. Bone morphogenetic protein family members are expressed during limb development, endochondral ossification, and early fracture and cartilage repair. Loss-of-function and gain-of-function studies have demonstrated the necessity and sufficiency of these genes, respectively, in regulating both cartilage and bone development. Several recent animal studies have demonstrated the potential of BMPs to enhance spinal fusion, repair critical-size defects, accelerate union, and heal articular cartilage lesions. A limited number of clinical trials using BMPs in human beings have been reported, and these agents are currently available for clinical use within and outside the United States. Current challenges to be met are the development of efficient delivery systems to present BMP proteins or genes to target sites and to enhance their duration and function at these locations.
authors.affiliation: Department of Orthopaedic Surgery, New York University Medical Center-Hospital for Joint Diseases Orthopaedic Institute, New York, New York 10003, USA.
authors.forename: Paul S
authors.initials: PS
authors.lastname: Issack
authors.forename: Paul E
authors.initials: PE
authors.lastname: DiCesare
mesh_terms: D000818:Animals; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins / Q000378:metabolism / Q000502:physiology / Q000627:therapeutic use*; D002358:Cartilage, Articular / Q000293:injuries / Q000503:physiopathology; D002478:Cells, Cultured; D016503:Drug Delivery Systems; D050723:Fractures, Bone / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D010003:Osteoarthritis / Q000503:physiopathology / Q000628:therapy; D013123:Spinal Fusion; D016212:Transforming Growth Factor beta; D014945:Wound Healing / Q000502:physiology
chemical_list: C525819:BMP7 protein, human; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins; D016212:Transforming Growth Factor beta